S&P also affirmed the “AA-” rating on MCCG’s $80.8 million of series 2009 bonds.
S&P’s analysis is based on the financial results of Navicent Health, MCCG’s parent organization.
“The rating reflects our view of Navicent Health’s solid and stable market share, growing net patient revenues, improved operating results and sound existing and pro forma balance sheet metrics,” said S&P credit analyst Charlene Butterfield.
The outlook is stable, reflecting S&P’s view of Navicent Health’s improved financial metrics, robust balance sheet and leading business position in central Georgia.
More articles on healthcare finance:
Moody’s assigns ‘Aa2′ rating to University of Iowa Hospitals and Clinics’ bonds
Calif. hospital slated to close fails to make payroll
Gallup: Uninsured rate at lowest point since 2008
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
